ERBB2 and breast carcinoma: Modeling cancer in mice was revolutionized with the description of some of the first transgenic mouse models of breast cancer expressing well known oncogenes like Myc [27], Ras [28] and Neu [29] under the control of the MMTV glucocorticoid regulated promoter enhancer [30].